10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Purification Methodology for Viable and Infective Plasmodium vivax Gametocytes That Is Compatible with Transmission-Blocking Assays.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Significant progress toward the control of malaria has been achieved, especially regarding Plasmodium falciparum infections. However, the unique biology of Plasmodium vivax hampers current control strategies. The early appearance of P. vivax gametocytes in the peripheral blood and the impossibility of culturing this parasite are major drawbacks. Using blood samples from 40 P. vivax-infected patients, we describe here a methodology to purify viable gametocytes and further infect anophelines. This method opens new avenues to validate transmission-blocking strategies.

          Related collections

          Author and article information

          Journal
          Antimicrob. Agents Chemother.
          Antimicrobial agents and chemotherapy
          American Society for Microbiology
          1098-6596
          0066-4804
          Oct 2015
          : 59
          : 10
          Affiliations
          [1 ] Departamento de Genética, Evolução e Bioagentes, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Gerência de Malária, Manaus, Amazonas, Brazil.
          [2 ] Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Gerência de Malária, Manaus, Amazonas, Brazil.
          [3 ] Departamento de Genética, Evolução e Bioagentes, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Curitiba, Paraná, Brazil.
          [4 ] Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Gerência de Malária, Manaus, Amazonas, Brazil Escola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil.
          [5 ] Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.
          [6 ] Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Gerência de Malária, Manaus, Amazonas, Brazil Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz (FIOCRUZ), Manaus, Amazonas, Brazil.
          [7 ] Departamento de Genética, Evolução e Bioagentes, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Gerência de Malária, Manaus, Amazonas, Brazil Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz (FIOCRUZ), Manaus, Amazonas, Brazil stefaniecplopes@gmail.com fabiotmc72@gmail.com.
          [8 ] Departamento de Genética, Evolução e Bioagentes, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil stefaniecplopes@gmail.com fabiotmc72@gmail.com.
          Article
          AAC.01136-15
          10.1128/AAC.01136-15
          4576123
          26239989
          04b436d0-10c4-4629-8222-efe818b509fc
          History

          Comments

          Comment on this article